Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

NCT02137109 · clinicaltrials.gov ↗

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: natalizumab

Sponsor

Biogen